Zoetis currently trades with a PEG ratio of 1.33, based on Jun 23, 2026 data. Dividing the 12.72 PE ratio by the 9.6% earnings growth rate produces this figure. Relative to the 2.18 average from the past four quarters, the PEG ratio has declined by 39%.
Historically, Zoetis has a PEG ratio averaging 3.31 across the last ten years. At 1.33, today's PEG ratio sits 60% less than its historical average. The ten years high came in the Mar 2023 quarter at 23.43, reflecting peak valuation relative to growth. The bottom was reached in the Dec 2016 quarter at 0.22, suggesting attractive value relative to growth during that period.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 2.05 | 20.87 | 10.2% |
| 2024 | 3.87 | 29.79 | 7.7% |
| 2023 | 3.08 | 38.85 | 12.6% |
| 2022 | 6.37 | 32.49 | 5.1% |
| 2021 | 2.3 | 56.88 | 24.7% |
| 2020 | 5.01 | 48.11 | 9.6% |
| 2019 | 6.91 | 42.15 | 6.1% |
| 2018 | 0.42 | 28.9 | 68.2% |
| 2017 | 6.82 | 40.93 | 6% |
| 2016 | 0.22 | 32.25 | 144.1% |
| 2015 | N/A | 70.47 | -41.4% |
| 2014 | 2.49 | 37.09 | 14.9% |
| 2013 | 2.01 | 32.37 | 16.1% |
| 2012 | N/A | N/A | 77.6% |
| 2011 | N/A | N/A | 122.7% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 2.04 | 19.57 | 9.6% |
| Dec 2025 | 2.05 | 20.87 | 10.2% |
| Sep 2025 | 2.47 | 24.93 | 10.1% |
| Jun 2025 | 2.17 | 27.12 | 12.5% |
| Mar 2025 | 4.82 | 29.88 | 6.2% |
| Dec 2024 | 3.87 | 29.79 | 7.7% |
| Sep 2024 | 4.42 | 36.66 | 8.3% |
| Jun 2024 | 4.59 | 33.93 | 7.4% |
| Mar 2024 | 1.93 | 32.6 | 16.9% |
| Dec 2023 | 3.08 | 38.85 | 12.6% |
| Sep 2023 | 2.92 | 35.36 | 12.1% |
| Jun 2023 | 4.7 | 36.18 | 7.7% |
| Mar 2023 | 23.43 | 37.49 | 1.6% |
| Dec 2022 | 6.37 | 32.49 | 5.1% |
| Sep 2022 | 6.37 | 33.78 | 5.3% |
When comparing to historical data, ZTS's PEG ratio is lower than the 3, 5 and 10-year averages.
Zoetis's PEG of 1.33 is higher than the Healthcare sector and the industry average. Looking at the Healthcare sector average of 0.56, Zoetis's PEG is 138% higher.
ZTS reports a PEG ratio higher than that of peer stocks LLY and PAHC.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| PAHC Phibro Animal Health Corp | 0.07 | $1.24B |
| LLY ELI LILLY & Co | 0.31 | $1.04T |
| ZTS Zoetis Inc | 1.33 | $32.21B |
| PFE Pfizer Inc | N/A | $140.89B |
| MRK Merck & Co Inc | N/A | $295.39B |
| ICCC Immucell Corp | N/A | $89.25M |
ZTS's Jun 23, 2026 PEG ratio comes in at 1.33.
ZTS has a 3-year average PEG ratio of 3.26.
ZTS has a 5-year average PEG ratio of 4.45.
In the last ten years, ZTS's peak PEG ratio of 23.43 occurred in the Mar 2023 quarter.
Compared to the 10-year average, ZTS's PEG ratio stands 60% lower.
The PEG ratio derives from taking PE and dividing by the rate at which earnings are growing (YoY TTM). As of Jun 23, 2026, Zoetis has a PE ratio of 12.72. Earnings grew at 9.6% over the TTM period ending Mar 2026. Applying the formula, this gives a PEG ratio of 1.33. PEG RATIO(1.33) = PE RATIO(12.72) / EPS GROWTH(9.6%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.